Rechercher | Socid Friendly

Rutuja Deshmukh Ajout d’un nouvel article Autre
2026-08-04 10:18:36

Anatomic Pathology Market Growth Analysis and Future Outlook
The global Anatomic Pathology Market is experiencing strong growth due to the rising prevalence of cancer and chronic diseases, increasing demand for tissue-based diagnostics, and rapid advancements in digital pathology technologies. Healthcare providers are increasingly relying on anatomic pathology for accurate disease diagnosis, classification, staging, and treatment planning,...

0 Commentaires 0 Parts 657 Vue

Connectez-vous pour aimer, partager et commenter!
Divya Kamate Ajout d’un nouvel article Autre
2026-04-16 06:20:35

Haemeto Oncology Testing Market: NGS, PCR & Hematologic Malignancy Diagnostics 2033
" Exactitude Consultancy That Adds Flavour To Your Success" Haemeto Oncology Testing Market size and forecast. NGS and PCR diagnostics for Leukemia, Lymphoma, and Myeloma across clinical laboratories. Exactitude Consultancy has just launched its latest market research report, titled "Haemeto Oncology Testing Market: Market Size, Share, Growth Outlook & Industry Analysis Report:...

0 Commentaires 0 Parts 1974 Vue

Connectez-vous pour aimer, partager et commenter!
Shimmmm Carter Ajout d’un nouvel article Autre
2026-01-27 07:32:33

Kidney Cancer Diagnostics Market – Molecular Testing Expansion, Early Detection Focus & Oncology Accuracy
"Detailed Analysis of Executive Summary Kidney Cancer Diagnostics Market Size and Share CAGR Value Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. Kidney Cancer Diagnostics Market research report is a great backbone for the expansion of Kidney...

0 Commentaires 0 Parts 3809 Vue

Connectez-vous pour aimer, partager et commenter!
Prasad Shinde

Ajout d’un nouvel article Autre
2026-08-18 07:40:20

Why Multi-Omics and Real-World Data Matter to AI in Oncology Growth
The AI in oncology market is entering a rapid expansion phase as healthcare providers, researchers, and pharmaceutical companies increasingly use artificial intelligence to improve cancer diagnostics, treatment planning, and research. The market was valued at USD 6.0 billion in 2025 and is projected to grow from USD 8.3 billion in 2026 to USD 38.9 billion by 2033, registering a CAGR of 24.8%...

0 Commentaires 0 Parts 422 Vue

Connectez-vous pour aimer, partager et commenter!